Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep (IMMP)
NASDAQ:IMMP
Immutep (IMMP) Stock Price & Analysis
571 Followers
IMMP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.50 - $3.90
Previous Close$2.82
Volume315.67K
Average Volume (3M)193.68K
Market Cap
$341.42M
Enterprise Value$261.62M
Total Cash (Recent Filing)AU$123.42M
Total Debt (Recent Filing)AU$1.23M
Price to Earnings (P/E)-10.9
Beta1.40
Next Earnings
Aug 28, 2024EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding1,187,306,209
10 Day Avg. Volume434,919
30 Day Avg. Volume193,678
Standard Deviation0.21
R-Squared0.30
Alpha0.00740
Financial Highlights & Ratios
Price to Book (P/B)25.15
Price to Sales (P/S)955.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8.50Price Target Upside201.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Immutep News
PremiumCompany Announcements
Immutep’s Efti Shows Promise in Sarcoma Trial
PremiumCompany Announcements
Immutep Shares Upbeat Clinical Trials Update
PremiumCompany Announcements
Immutep’s Efti Shows Promise in Cancer Trial
PremiumCompany Announcements
Immutep Advances Novel Autoimmune Therapy with Phase I Trial
Ownership Overview
0.00%
Insiders
0.05% Mutual Funds
0.81% Other Institutional Investors
99.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMMP FAQ
What was Immutep’s price range in the past 12 months?
Immutep lowest stock price was $1.50 and its highest was $3.90 in the past 12 months.
What is Immutep’s market cap?
Currently, no data Available
When is Immutep’s upcoming earnings report date?
Immutep’s upcoming earnings report date is Aug 28, 2024 which is in 112 days.
How were Immutep’s earnings last quarter?
Immutep released its earnings results on Feb 27, 2024. The company reported -$0.116 earnings per share for the quarter, beating the consensus estimate of -$0.134 by $0.018.
Is Immutep overvalued?
According to Wall Street analysts Immutep’s price is currently Undervalued.
Does Immutep pay dividends?
Immutep does not currently pay dividends.
What is Immutep’s EPS estimate?
Immutep’s EPS estimate is -$0.12.
How many shares outstanding does Immutep have?
Immutep has 118,883,450 shares outstanding.
What happened to Immutep’s price movement after its last earnings report?
Immutep reported an EPS of -$0.116 in its last earnings report, beating expectations of -$0.134. Following the earnings report the stock price went down -2.146%.
Which hedge fund is a major shareholder of Immutep?
Among the largest hedge funds holding Immutep’s share is Oracle Investment Management Inc. It holds Immutep’s shares valued at 1M.
---
Immutep Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (201.42% Upside)
$8.50 (201.42% Upside)
Blogger Sentiment
Bullish
IMMP Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 6.1%
Last 30 Days ▲ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.53%
12-Months-Change
Fundamentals
Return on Equity
-41.05%
Trailing 12-Months
Asset Growth
44.82%
Trailing 12-Months
Company Description
Immutep
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
IMMP Stock 12 Month Forecast
Average Price Target
$8.50
▲(201.42% Upside)
Technical Analysis
Best Analysts Covering IMMP
1 Year
1 Year Success Rate
7/10 ratings generated profit
1 Year Average Return
+11.39%
reiterated a buy rating 15 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +11.39% per trade.
---